238 related articles for article (PubMed ID: 11527964)
1. Crystal structure of Bruton's tyrosine kinase domain suggests a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemia.
Mao C; Zhou M; Uckun FM
J Biol Chem; 2001 Nov; 276(44):41435-43. PubMed ID: 11527964
[TBL] [Abstract][Full Text] [Related]
2. B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia.
de Weers M; Brouns GS; Hinshelwood S; Kinnon C; Schuurman RK; Hendriks RW; Borst J
J Biol Chem; 1994 Sep; 269(39):23857-60. PubMed ID: 7929028
[TBL] [Abstract][Full Text] [Related]
3. Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis.
Mattsson PT; Lappalainen I; Bäckesjö CM; Brockmann E; Laurén S; Vihinen M; Smith CI
J Immunol; 2000 Apr; 164(8):4170-7. PubMed ID: 10754312
[TBL] [Abstract][Full Text] [Related]
4. Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia.
Hyvönen M; Saraste M
EMBO J; 1997 Jun; 16(12):3396-404. PubMed ID: 9218782
[TBL] [Abstract][Full Text] [Related]
5. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.
Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE
Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900
[TBL] [Abstract][Full Text] [Related]
6. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.
Saha BK; Curtis SK; Vogler LB; Vihinen M
Mol Med; 1997 Jul; 3(7):477-85. PubMed ID: 9260159
[TBL] [Abstract][Full Text] [Related]
7. BTK, the tyrosine kinase affected in X-linked agammaglobulinemia.
Vihinen M; Mattsson PT; Smith CI
Front Biosci; 1997 Jan; 2():d27-42. PubMed ID: 9159207
[TBL] [Abstract][Full Text] [Related]
8. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.
Hashimoto S; Tsukada S; Matsushita M; Miyawaki T; Niida Y; Yachie A; Kobayashi S; Iwata T; Hayakawa H; Matsuoka H; Tsuge I; Yamadori T; Kunikata T; Arai S; Yoshizaki K; Taniguchi N; Kishimoto T
Blood; 1996 Jul; 88(2):561-73. PubMed ID: 8695804
[TBL] [Abstract][Full Text] [Related]
9. X-linked agammaglobulinemia and Bruton's tyrosine kinase.
Tsukada S; Witte ON
Adv Exp Med Biol; 1994; 365():233-8. PubMed ID: 7887309
[No Abstract] [Full Text] [Related]
10. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
[TBL] [Abstract][Full Text] [Related]
11. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia.
Vorechovský I; Vihinen M; de Saint Basile G; Honsová S; Hammarström L; Müller S; Nilsson L; Fischer A; Smith CI
Hum Mol Genet; 1995 Jan; 4(1):51-8. PubMed ID: 7711734
[TBL] [Abstract][Full Text] [Related]
12. Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).
Vihinen M; Mattsson PT; Smith CI
Front Biosci; 2000 Dec; 5():D917-28. PubMed ID: 11102316
[TBL] [Abstract][Full Text] [Related]
13. X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease.
Mattsson PT; Vihinen M; Smith CI
Bioessays; 1996 Oct; 18(10):825-34. PubMed ID: 8885720
[TBL] [Abstract][Full Text] [Related]
14. Structure of the PH domain from Bruton's tyrosine kinase in complex with inositol 1,3,4,5-tetrakisphosphate.
Baraldi E; Djinovic Carugo K; Hyvönen M; Surdo PL; Riley AM; Potter BV; O'Brien R; Ladbury JE; Saraste M
Structure; 1999 Apr; 7(4):449-60. PubMed ID: 10196129
[TBL] [Abstract][Full Text] [Related]
15. Identification of nine novel mutations in the Bruton's tyrosine kinase gene in X-linked agammaglobulinaemia patients.
Orlandi P; Ritis K; Moschese V; Angelini F; Arvanitidis K; Speletas M; Sideras P; Plebani A; Rossi P
Hum Mutat; 2000 Jan; 15(1):117. PubMed ID: 10612838
[TBL] [Abstract][Full Text] [Related]
16. Point mutation in intron 11 of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia.
Shinomiya N; Kanegane H; Watanabe A; Yamaguchi Y; Futatani T; Miyawaki T
Pediatr Int; 2000 Dec; 42(6):689-92. PubMed ID: 11192530
[No Abstract] [Full Text] [Related]
17. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
[TBL] [Abstract][Full Text] [Related]
18. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
Vihinen M; Belohradsky BH; Haire RN; Holinski-Feder E; Kwan SP; Lappalainen I; Lehväslaiho H; Lester T; Meindl A; Ochs HD; Ollila J; Vorechovsky I; Weiss M; Smith CI
Nucleic Acids Res; 1997 Jan; 25(1):166-71. PubMed ID: 9016530
[TBL] [Abstract][Full Text] [Related]
19. Role of Bruton's tyrosine kinase in immunodeficiency.
Tsukada S; Rawlings DJ; Witte ON
Curr Opin Immunol; 1994 Aug; 6(4):623-30. PubMed ID: 7946052
[TBL] [Abstract][Full Text] [Related]
20. Structural basis of SH2 domain mutations in X-linked agammaglobulinemia.
Vihinen M; Nilsson L; Smith CI
Biochem Biophys Res Commun; 1994 Dec; 205(2):1270-7. PubMed ID: 7528500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
